XCSE
DADC
Market cap11mUSD
Jun 04, Last price
6.70DKK
Name
Danish Aerospace Company A/S
Chart & Performance
P/E
—
P/S
3.90
EPS
—
Div Yield, %
—
Shrs. gr., 5y
3.82%
Rev. gr., 5y
-3.07%
Revenues
19m
+0.13%
Net income
-4m
L-9.73%
CFO
1m
-74.54%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Danish Aerospace Company A/S designs, develops, manufactures, and sells medical monitoring and exercise equipment. It offers agile data analyzer and monitor, a medical software that supports loading data over a network connection; portable pulmonary function systems for use in the areas of respiratory, cardiovascular, and metabolic physiology; cycle ergometer with vibration isolation and stabilization system, a recumbent bicycle that provides aerobic exercise for the harmful physiological effects of exposure to microgravity; advanced respiratory monitoring systems; European enhanced exploration exercise devices; shuttle ergometer; and flight ergometer, the next generation space ergometer. The company provides respiratory monitoring systems-II equipment, a photo- and magnetoacoustic multi-gas analyzer for performing non-invasive cardiovascular and pulmonary measurements; and European gas delivery system, a specially developed gas cylinder used for calibration and measurement of equipment and/or as breathing gases for use in space. The company was founded in 1988 and is based in Odense, Denmark.
Valuation
Title DKK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||